We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $17.3B
1-Year Est. Return 211.34%
This Fund
S&P 500
This Quarter Est. Return
+52.81%
1 Year Est. Return
+211.34%
3 Year Est. Return
+939.3%
5 Year Est. Return
+2,115.56%
10 Year Est. Return
+44,753.23%
AUM
$17.3B
AUM Growth
+$3.65B
Cap. Flow
-$454M
Cap. Flow %
-2.63%
Top 10 Hldgs %
16.32%
Holding
439
New
84
Increased
139
Reduced
108
Closed
85

Top Sells

Rank Stock Value
1
FN icon
Fabrinet
FN
+$240M
2
LITE icon
Lumentum
LITE
+$130M
3
BE icon
Bloom Energy
BE
+$118M
4
TSM icon
TSMC
TSM
+$114M
5
COHR icon
Coherent
COHR
+$90.8M

Sector Composition

Rank Sector Weight
1 Healthcare 27.73%
2 Technology 23.9%
3 Industrials 19.67%
4 Financials 9.01%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FN icon
276
Fabrinet
FN
$15.2B
$10.1M 0.06%
17,971
-373,110
-95% -$240M
GFI icon
277
Gold Fields
GFI
$42.4B
$10.1M 0.06%
300,555
+4,816
+2% +$201K
ANIP icon
278
ANI Pharmaceuticals
ANIP
$1.63B
$10.1M 0.06%
121,852
+393
+0.3% +$31.5K
LRMR icon
279
Larimar Therapeutics
LRMR
$400M
$9.65M 0.06%
3,163,423
+229,024
+8% +$909K
CTRN icon
280
Citi Trends
CTRN
$580M
$9.45M 0.05%
+163,425
New +$7.83M
CUE icon
281
Cue Biopharma
CUE
$206M
$9.22M 0.05%
+292,144
New +$6.61M
GRRR
282
Gorilla Technology Group
GRRR
$403M
$9.19M 0.05%
+462,051
New +$6.95M
SII
283
Sprott
SII
$3.36B
$9.07M 0.05%
80,500
-2,600
-3% -$340K
PRSU
284
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
$8.01M 0.05%
+143,056
New +$6.32M
MNPR icon
285
Monopar Therapeutics
MNPR
$775M
$7.78M 0.05%
84,040
+50,884
+153% +$3.15M
DTIL icon
286
Precision BioSciences
DTIL
$204M
$7.44M 0.04%
946,707
-48,664
-5% -$342K
AS icon
287
Amer Sports
AS
$16.9B
$7.2M 0.04%
212,880
+6,380
+3% +$224K
SPIR icon
288
Spire Global
SPIR
$491M
$6.89M 0.04%
+370,379
New +$6.89M
TSSI
289
TSS Inc
TSSI
$245M
$6.6M 0.04%
+536,314
New +$7.23M
KRRO icon
290
Korro Bio
KRRO
$192M
$5.93M 0.03%
450,045
SI
291
Shoulder Innovations Inc
SI
$418M
$5.15M 0.03%
+253,760
New +$3.9M
KARD
292
Kardigan Inc
KARD
$2.02B
$4.76M 0.03%
+199,612
New +$4.62M
NGNE icon
293
Neurogene
NGNE
$752M
$4.51M 0.03%
143,528
+110,763
+338% +$3.05M
IPI icon
294
Intrepid Potash
IPI
$555M
$4.26M 0.02%
129,979
-183,909
-59% -$7M
IVVD icon
295
Invivyd
IVVD
$246M
$4.19M 0.02%
4,806,543
-3,630,351
-43% -$4.55M
ASMB icon
296
Assembly Biosciences
ASMB
$718M
$4.12M 0.02%
+150,000
New +$4.08M
GOOGL icon
297
Alphabet (Google) Class A
GOOGL
$4.14T
$3.67M 0.02%
10,273
-1,450
-12% -$522K
PAM icon
298
Pampa Energía
PAM
$4.59B
$3.55M 0.02%
43,172
+21,919
+103% +$1.83M
NVDA icon
299
NVIDIA
NVDA
$5.45T
$3.17M 0.02%
15,853
-1,028
-6% -$211K
AMZN icon
300
Amazon
AMZN
$2.77T
$3.16M 0.02%
13,239
+5,917
+81% +$1.49M

Similar funds

Driehaus Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Driehaus Capital Management held 439 positions worth $17.3B, up 27% from $13.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Driehaus Capital Management's Q2 2026 filing shows 84 new, 139 increased, 108 reduced and 85 closed positions. Its largest new stake was Cadence Design Systems: 293,693 shares worth $110M. The largest sale was Fabrinet, an estimated $240M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

  • Driehaus Capital Management's largest Q2 2026 buy was Cadence Design Systems: 293,693 shares worth $110M.
  • Driehaus Capital Management added most to Vicor in Q2 2026, an estimated $83.8M increase.
  • Driehaus Capital Management's biggest Q2 2026 reduction was Fabrinet, cutting an estimated $240M.
  • Driehaus Capital Management fully exited National Vision in Q2 2026, selling an estimated $89.9M.
  • Driehaus Capital Management's ten largest holdings make up 16% of its $17.3B portfolio in Q2 2026.
  • Driehaus Capital Management opened 84 new positions and closed 85 in Q2 2026.
  • Driehaus Capital Management's portfolio value rose 27% quarter-over-quarter to $17.3B.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.